Interferon-alpha treatment for severe atopic dermatitis.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 8607568.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Patients with both severe atopic dermatitis (AD) and chronic myeloid leukemia, chronic hepatitis B, or chronic hepatitis C were treated with interferon-alpha (IFN-alpha). IFN-alpha treatment improved AD. Moreover, there were also significant decreases in serum IgE and IgG4 levels and in in vitro spontaneous IgE and IgG4 production by patients' mononuclear cells.
Medical subject headings
- Dermatitis, Atopic
- Interferon-alpha